NCT01916928View on ClinicalTrials.gov

The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

December 31, 2014

Conditions
Circulating Cell Free Fetal DNAIntrauterine Fetal DemiseMiscarriage
Trial Locations (1)

20010

Medstar Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Sequenom Laboratories

UNKNOWN

lead

Medstar Health Research Institute

OTHER